HomeTEM • NASDAQ
add
Tempus AI Inc
Previous close
$68.36
Day range
$66.66 - $68.95
Year range
$36.22 - $104.32
Market cap
11.93B USD
Avg Volume
4.75M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 334.21M | 84.72% |
Operating expense | 270.39M | 69.57% |
Net income | -79.98M | -5.46% |
Net profit margin | -23.93 | 42.92% |
Earnings per share | -0.11 | 56.00% |
EBITDA | -40.64M | 8.00% |
Effective tax rate | -0.35% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 759.64M | 62.90% |
Total assets | 2.28B | 134.78% |
Total liabilities | 1.77B | 93.20% |
Total equity | 507.82M | — |
Shares outstanding | 177.91M | — |
Price to book | 23.90 | — |
Return on assets | -7.74% | — |
Return on capital | -10.05% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -79.98M | -5.46% |
Cash from operations | -119.84M | -346.26% |
Cash from investing | -2.31M | 98.24% |
Cash from financing | 594.69M | 7,421.06% |
Net change in cash | 472.50M | 620.41% |
Free cash flow | -98.07M | -435.75% |
About
Tempus AI, Inc. is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. Tempus uses data and artificial intelligence to create precision medicine services, including diagnostics, for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM." Wikipedia
Founded
2015
Headquarters
Website
Employees
2,400
